| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Gold Daniel Allen | Director | C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM | /s/ Dan Gold | 21 Nov 2025 | 0001832142 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ROIV | Common Shares | Sale | -$17.2M | -850K | -4.39% | $20.25 | 18.5M | 19 Nov 2025 | Held by QVT Financial Investment Cayman Ltd. | F1 |
| transaction | ROIV | Common Shares | Sale | -$3.03M | -150K | -0.81% | $20.20 | 18.3M | 19 Nov 2025 | Held by QVT Financial Investment Cayman Ltd. | F1 |
| transaction | ROIV | Common Shares | Sale | -$2.52M | -125K | -0.68% | $20.16 | 18.2M | 19 Nov 2025 | Held by QVT Financial Investment Cayman Ltd. | F1 |
| transaction | ROIV | Common Shares | Sale | -$3.54M | -175K | -0.96% | $20.24 | 18M | 19 Nov 2025 | Held by QVT Financial Investment Cayman Ltd. | F1 |
| Id | Content |
|---|---|
| F1 | The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose. |